The first AI system for human embryonic state analysis is available for testing

IMAGE: This is the Insilico Medicine logo. view more Credit: Insilico Medicine Tuesday, July 5, 2016, Baltimore, MD – At Mensa Annual Gathering 2016, the annual event of the largest and oldest high IQ society transpiring in San Diego from June 29th to July 3rd, Dr. Michael West, CEO of BioTime, Inc announced the launch of a beta version of Embryonic.AI, an artificially intelligent system for analyzing the embryonic state of human cell samples using gene expression data. The first implementation of Embryonic.AI was launched by LifeMap Discovery, Inc, a subsidiary of BioTime, Inc and is freely available for beta testing. Scientists and companies from all over the world are welcome to test their stem cell and adult cell samples using Embryonic.AI and discuss collaboration alternatives. A brief video provides a…


Link to Full Article: The first AI system for human embryonic state analysis is available for testing